Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moloy Banerjee

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Drug Design, Development and Therapy|April 25, 2017
Phenotypic evaluation and in silico ADMET properties of novel arylimidamides in acute mouse models of <i>Trypanosoma cruzi</i> infectionCristiane França da Silva, Denise da Gama Jaén Batista, Julianna Siciliano de Araújo, et al.
Chembiochem : a European Journal of Chemical Biology|December 11, 2013
Structure-dependent binding of arylimidamides to the DNA minor grooveYun Chai, Manoj Munde, Arvind Kumar, et al.
Antimicrobial Agents and Chemotherapy|April 18, 2012
Evaluation of arylimidamides DB1955 and DB1960 as candidates against visceral leishmaniasis and Chagas' disease: in vivo efficacy, acute toxicity, pharmacokinetics, and toxicology studiesXiaohua Zhu, Qiang Liu, Sihyung Yang, et al.
Journal of Medicinal Chemistry|November 12, 2019
Discovery and Characterization of Potent Pan-Genotypic HCV NS5A Inhibitors Containing Novel Tricyclic Central Core Leading to Clinical CandidateVidya Ramdas, Rashmi Talwar, Moloy Banerjee, et al.
Journal of Medicinal Chemistry|May 6, 2020
Discovery of Potent, Selective, and State-Dependent Na<sub>V</sub>1.7 Inhibitors with Robust Oral Efficacy in Pain Models: Structure-Activity Relationship and Optimization of Chroman and Indane Aryl SulfonamidesVidya Ramdas, Rashmi Talwar, Vijay Kanoje, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Drug Design, Development and Therapy|April 25, 2017
Phenotypic evaluation and in silico ADMET properties of novel arylimidamides in acute mouse models of <i>Trypanosoma cruzi</i> infectionCristiane França da Silva, Denise da Gama Jaén Batista, Julianna Siciliano de Araújo, et al.
Chembiochem : a European Journal of Chemical Biology|December 11, 2013
Structure-dependent binding of arylimidamides to the DNA minor grooveYun Chai, Manoj Munde, Arvind Kumar, et al.
Antimicrobial Agents and Chemotherapy|April 18, 2012
Evaluation of arylimidamides DB1955 and DB1960 as candidates against visceral leishmaniasis and Chagas' disease: in vivo efficacy, acute toxicity, pharmacokinetics, and toxicology studiesXiaohua Zhu, Qiang Liu, Sihyung Yang, et al.
Journal of Medicinal Chemistry|November 12, 2019
Discovery and Characterization of Potent Pan-Genotypic HCV NS5A Inhibitors Containing Novel Tricyclic Central Core Leading to Clinical CandidateVidya Ramdas, Rashmi Talwar, Moloy Banerjee, et al.
Journal of Medicinal Chemistry|May 6, 2020
Discovery of Potent, Selective, and State-Dependent Na<sub>V</sub>1.7 Inhibitors with Robust Oral Efficacy in Pain Models: Structure-Activity Relationship and Optimization of Chroman and Indane Aryl SulfonamidesVidya Ramdas, Rashmi Talwar, Vijay Kanoje, et al.
Pageof 2